Article thumbnail

Catabolism of Branched-Chain Amino Acids in Heart Failure: Insights from Genetic Models

By Haipeng Sun, Gang Lu, Shuxun Ren, Jaunian Chen and Yibin Wang

Abstract

Genetic defects in amino acid metabolism are major causes of newborn diseases that often lead to abnormal development and function of the central nervous system. Their direct impact on cardiac development and function has rarely been investigated. Recently, the authors have established that a mitochondrial targeted 2C-type ser/thr protein phosphatase, PP2Cm, is the endogenous phosphatase of the branched-chain alpha keto acid-dehydrogenase complex (BCKD) and functions as a key regulator in branched-chain amino acid catabolism and homeostasis. Genetic inactivation of PP2Cm in mice leads to significant elevation in plasma concentrations of branched-chain amino acids and branched-chain keto acids at levels similar to those associated with intermediate mild forms of maple syrup urine disease. In addition to neuronal tissues, PP2Cm is highly expressed in cardiac muscle, and its expression is diminished in a heart under pathologic stresses. Whereas phenotypic features of heart failure are seen in PP2Cm-deficient zebra fish embryos, cardiac function in PP2Cm-null mice is compromised at a young age and deteriorates faster by mechanical overload. These observations suggest that the catabolism of branched-chain amino acids also has physiologic significance in maintaining normal cardiac function. Defects in PP2Cm-mediated catabolism of branched-chain amino acids can be a potential novel mechanism not only for maple syrup urine disease but also for congenital heart diseases and heart failure

Topics: Riley Symposium
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:3051105
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development.
  2. (2010). Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain.
  3. (2009). Amino acid regulation of TOR complex 1.
  4. (1984). Branched-chain amino acid metabolism. Annu Rev Nutr 4:409–454
  5. (2005). Branched-chain amino acids and brain function.
  6. (2010). Branched-chain amino acids induce neurotoxicity in rat cortical cultures.
  7. (1991). Comparison of the effects of various amino acids on glycogen synthesis, lipogenesis, and ketogenesis in isolated rat hepatocytes.
  8. (1998). Maple syrup urine disease: it has come a long way.
  9. (2004). Mechanisms responsible for regulation of branched-chain amino acid catabolism.
  10. (2009). mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat.
  11. (2006). Newborn screening fact sheets. Pediatrics 118:e934–e963